BIO-key International Inc. (NASDAQ:BKYI) Sees Significant Drop in Short Interest

BIO-key International Inc. (NASDAQ:BKYI – Get Free Report) was the recipient of a significant decline in short interest during the month of September. As of September 15th, there was short interest totaling 6,628 shares, a decline of 39.1% from the August 31st total of 10,889 shares. Currently, 0.5% of the shares of the stock are short sold. Based on an average daily volume of 12,544 shares, the days-to-cover ratio is currently 0.5 days.

BIO-key International Price Performance

BKYI stock opened at $2.12 on Friday. The company’s 50 day simple moving average is $3.11 and its 200-day simple moving average is $4.34. BIO-key International has a 12 month low of $1.63 and a 12 month high of $19.70. The firm has a market capitalization of $3.04 million, a PE ratio of -0.52 and a beta of 0.50.

BIO-key International (NASDAQ:BKYI – Get Free Report) last issued its quarterly earnings data on Thursday, August 13th. The technology company reported ($0.56) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.82) by $0.26. The firm had revenue of $1.92 million during the quarter, compared to the consensus estimate of $1.80 million. BIO-key International had a negative return on equity of 67.31% and a negative net margin of 50.01%. As a group, sell-side analysts anticipate that BIO-key International will post -1.62 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have weighed in on BKYI shares. Zacks Research raised BIO-key International to a “hold” rating in a report on Thursday, August 6th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a research note on Friday, July 17th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, BIO-key International has an average rating of “Reduce”.

Read Our Latest Analysis on BKYI

About BIO-key International

(Get Free Report)

BIO-key International, Inc develops biometric identity and access management solutions designed to help organizations secure applications, devices and networks. Its offerings use fingerprint authentication and other authentication methods to provide alternatives or supplements to passwords, supporting secure access for employees, students, customers and other users.

The company’s products include biometric readers and related software, as well as its PortalGuard identity and access management platform.

See Also

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.